2020 Year in Review - Multiple Myeloma

2020 Year in Review - Multiple Myeloma - Multiple Myeloma
Related Items
CAR T-Cell Therapy Shows Deep, Durable Responses in Relapsed or Refractory Multiple Myeloma
Charlie Dawson
TOP - September 2020 Vol 13, No 5 published on September 14, 2020 in Multiple Myeloma
Bortezomib, Lenalidomide, and Dexamethasone Remains Standard of Care for Initial Treatment of Patients with Newly Diagnosed Multiple Myeloma
Charlie Dawson
TOP - September 2020 Vol 13, No 5 published on September 14, 2020 in Multiple Myeloma
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Web Exclusives published on October 22, 2019 in Breast Cancer, FDA Updates, In the News, Multiple Myeloma, Pediatric Cancer
Darzalex Combination Receives Approval for First-Line Treatment of Patients with Multiple Myeloma Eligible for Transplant
Web Exclusives published on September 30, 2019 in FDA Updates, In the News, Multiple Myeloma
Once-Weekly Carfilzomib for Patients with Relapsed or Refractory Multiple Myeloma Improves Progression-Free Survival
Walter Alexander
Web Exclusives published on October 9, 2018 in Multiple Myeloma
Pomalidomide Added to the Regimen in First Relapse Extends PFS in Multiple Myeloma
Wayne Kuznar
Web Exclusives published on October 9, 2018 in Multiple Myeloma
Investigational CAR T-Cell Therapy, bb2121, Shows Durable Responses in Relapsed or Refractory Multiple Myeloma
Web Exclusives published on October 9, 2018 in Immunotherapy, Multiple Myeloma
Revlimid (Lenalidomide) First Drug Approved for Post-Transplant Maintenance Therapy in Multiple Myeloma
Lisa A. Raedler, PhD, RPh, Medical Writer
2018 Third Annual Oncology Guide to New FDA Approvals published on May 9, 2018 in FDA Updates, Multiple Myeloma
Daratumumab Added to Carfilzomib, Lenalidomide, and Dexamethasone: Safe and Tolerable in Patients with Newly Diagnosed Multiple Myeloma
Chase Doyle
TOP - November 2017, Vol 10, No 4 published on November 13, 2017 in Multiple Myeloma
New Drug Therapies for Relapsed or Refractory Multiple Myeloma
Meg Barbor, MPH
TOP - August 2017, Vol 10, No 3 published on August 1, 2017 in Multiple Myeloma
Last modified: November 29, 2020